Contrast enhancement in cardiac MDCT: comparison of iodixanol 320 versus iohexol 350.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The objective of our study was to evaluate whether iodixanol 320 mg I/mL (iodixanol 320), with the highest iodine concentration of dimeric nonionic contrast agents on the market, results in decreased vascular or myocardial enhancement compared with iohexol 350 mg I/mL (iohexol 350).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): AJR Am J Roentgenol

Title: AJR. American journal of roentgenology

Publisher: American Roentgen Ray Society

ISSN (Electronic): 1546-3141

ISSN (Print): 0361-803X

Publication date (Electronic): Jan 2008

Volume: 190

Issue: 1

Affiliations

[1 ] Department of Radiology, 407, Taichung Veterans General Hospital, No. 160, Section 3, Taichung Harbor Rd., Taichung, Taiwan, ROC. sillyduck.radiology@gmail.com

Article

Publisher Item ID: 190/1/W47

DOI: 10.2214/AJR.07.2541

PubMed ID: 18094272

SO-VID: 20533153-d8a4-4c95-854b-ebfc748ecf8d

History

Data availability:

Comments

Comment on this article

scite_

Cited by 4

See all cited by